HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

ISP: Wayne, N.J.-based International Specialty Products, Inc. targets new Natriance skin-care range to mass-market manufacturers looking to inject excitement into their line and boost results "without hurting their pocketbooks." Natriance consists of three products "derived from natural sources." Natriance Hydrator employs a bioelement derived from peas to increase filaggrin expression and elevate glycosaminoglycan levels, so that it "preserves bound water in the skin" and, based on in vitro testing, "boosts markers associated with skin hydration while optimizing the skin barrier," ISP asserts. Natriance Destresser features Oryza sativa bran extract to combat oxidative stress and minimize damage from UV exposure, while Natriance Brighter targets melanocytes with yeast extract to address overproduction of pigments that cause dark spots. According to ISP, its brightening ingredient is cheaper than other options and has been demonstrated in testing to be "more efficacious than popular standard methods such as the application of kojic acid." Company's Anna Gripp, senior director of global marketing, personal care, states: "Once reserved mostly for the higher end of the market, these benefits are now available to everyone, and we're very excited to roll them out for the mass market." More Natriance innovations are coming down the pipeline, firm says

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel